Several key policies to stop the spread of COVID-19 were generally a good idea in hindsight according to majority of Americans

Pfiz­er, Nvidia and Ther­mo Fish­er have pitched in to help a ma­chine learn­ing firm am­pli­fy its AI ap­proach, which could help bio­phar­ma com­pa­nies bet­ter suc­ceed

Syn­cona, the ma­jor­i­ty share­hold­er of Free­line Ther­a­peu­tics, has made a bid to ac­quire the biotech less than a month af­ter it re­vealed da­ta from two